Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 17
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis
Zihan Tang, Yanyan Xu, Yun Tan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Acute Pulmonary Embolism and Immunity in Animal Models
Anna M. Imiela, T. Mikołajczyk, Tomasz J. Guzik, et al.
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Open Access | Times Cited: 6
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 5
Inflammatory Heart Disease in Multisystem Inflammatory Syndrome
Giulia La Vecchia, Marco Giuseppe Del Buono, Aldo Bonaventura, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Open Access
Immunothrombotic involvement in COVID-19
José A. Páramo, María Marcos‐Jubilar
Elsevier eBooks (2025), pp. 335-352
Closed Access
Colchicine for cardiovascular prevention: the dawn of a new era has finally come
Aldo Bonaventura, Antonio Abbate
European Heart Journal (2023) Vol. 44, Iss. 35, pp. 3303-3304
Open Access | Times Cited: 13
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
Yikan Sun, Can Wang, Peiquan Lin, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 4, pp. 307-324
Open Access | Times Cited: 4
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
Nicola Potere, Aldo Bonaventura, Antonio Abbate
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 12, pp. 2371-2395
Closed Access | Times Cited: 3
The intersection of coagulation activation and inflammation after injury: What you need to know
Todd W. Costantini, Lucy Z. Kornblith, Timothy A. Pritts, et al.
Journal of Trauma and Acute Care Surgery (2023) Vol. 96, Iss. 3, pp. 347-356
Open Access | Times Cited: 8
Role of Colchicine in Cardiovascular Disorders
Errol Moras, Lakshmi Subramanian, Francisco José Romeo, et al.
Cardiology in Review (2024)
Closed Access | Times Cited: 2
IL-1 blockade in cardiovascular disease: an appraisal of the evidence across different inflammatory paradigms
Aldo Bonaventura, Francesco Moroni, Michele Golino, et al.
Minerva Cardiology and Angiology (2023) Vol. 72, Iss. 5
Closed Access | Times Cited: 6
NLRC4‐mediated pyroptosis was involved in coagulation disorders of acute pancreatitis
Sunkuan Hu, Tiesu Lin, Yufeng Chen, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 4
Closed Access | Times Cited: 1
Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19
Xiaoyong TAN, Xiaojun GAO, Huanhuan ZHENG, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 5
Closed Access | Times Cited: 1
Megakaryocyte in sepsis: the trinity of coagulation, inflammation and immunity
Tianzhen Hua, Feng-hua Yao, Haitao Wang, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 1
Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease
Felicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19
Alicia S. Eustes, Azaj Ahmed, Jagadish Swamy, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 9, pp. 2514-2530
Open Access
Discovery of crucial cytokines associated with deep vein thrombus formation by protein array analysis
Qitao Wang, Junyu Chi, Wenjie Zeng, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Inmunotrombosis: un mecanismo clave en la pandemia por COVID-19
José A. Páramo, María Marcos‐Jubilar
Medicina Clínica (2024) Vol. 163, Iss. 10, pp. 517-521
Closed Access
Immunothrombosis: A key mechanism in the COVID-19 pandemic
José A. Páramo, María Marcos‐Jubilar
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 10, pp. 517-521
Closed Access
SARS-CoV-2 N protein induces alveolar epithelial apoptosis via NLRP3 pathway in ARDS
Xiaopei Huang, Wenliang Zhu, Huifeng Zhang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113503-113503
Closed Access
Verbenalin Protects Against Coronavirus Pneumonia by Promoting Host Immune Homeostasis Via the Pink1/Parkin/Nlrp3 Pathways
Qiyue Sun, Ronghua Zhao, Shuran Li, et al.
(2024)
Closed Access
Functional anti-inflammatory mesoporous silica nanoplatform for Synergistic and Targeted abdominal aortic aneurysm treatment
Zhaoyu Wu, Xiaoyu Wu, Xianfang Meng, et al.
Journal of Colloid and Interface Science (2024) Vol. 683, pp. 1040-1054
Closed Access
Page 1 - Next Page

Scroll to top